EMA Issues Detailed Guidance on Drug Shortage Prevention Plans for Manufacturers

The European Medicines Agency (EMA) has released comprehensive guidance outlining updated requirements for drug manufacturers regarding shortage prevention plans. This guidance is issued under the new forthcoming pharmaceutical legislation and the planned Critical Medicines Act, aiming to ensure a stable supply of medicines within the EU and prevent critical shortages.